glp-1 drugs for parkinson's disease Incretin and insulin signaling as novel therapeutic targets Alzheimer's and Beyond insulin: The Intriguing role
Description
It serves a critical, life-sustaining role for type 1 patients who produce no insulin
8 The ASA guidelines consider the pharmacological half-life of the specific GLP-1-RA in use
Jafari-Vayghan, H., Varshosaz, P., Hajizadeh-Sharafabad, F., Razmi, H
D.BeatonN.ArnoldM.RudofskyG.LanghansW.WolfrumC
doi: 10.1007/s40256-024-00707-8 36 American Diabetes Association Professional Practice Committee
